Lux Biosciences to Present at RBC Capital Markets Healthcare Conference.

PR Newswire;  December 7, 2006 ;     414 words ......company specialized in the field of ophthalmic diseases, announced today that Ulrich Grau...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

Lux Biosciences Announces Exclusive Worldwide License Agreement with NIH...

PR Newswire;  November 7, 2006 ;     700+ words ......company specialized in the field of ophthalmic diseases, announced today the inclusion of...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

Lux Biosciences Receives FDA Clearance for LX211 IND.

PR Newswire;  November 28, 2006 ;     700+ words ......company specialized in the field of ophthalmic diseases, announced today that the 30- day...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

WIPO: Inventor in California Develops Ophthalmic Diseases Treatment...

US Fed News Service, Including US State News;  October 10, 2008 ;     178 words ......methods of using inhibitors (including monoclonal antibodies) directed against amyloid-beta peptide for the treatment of ophthalmic diseases such as age-related macular degeneration are described." The invention carries International Patent Publication No. WO...

Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of its...

PR Newswire;  February 20, 2007 ;     700+ words ......company specialized in the field of ophthalmic diseases, announced today that the company...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

Lux Biosciences Establishes European-Based Operations.

PR Newswire;  September 18, 2006 ;     621 words ......company specialized in the field of ophthalmic diseases, today announced that it has established...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

Light bloodwork.(laser diodes from CeramOptec Inc. for the treatment of...

Chemistry and Industry;  January 2, 2006 ;     257 words ...Laser treatments are used to treat several different ophthalmic diseases or indications. Argon and Krypton lasers are popular because the wavelengths they produce (488nm or 514nm, and 648nm, respectively...

OPKO Health Appoints Industry Veteran Dr. Naveed Shams as Chief Medical...

PR Newswire;  January 14, 2008 ;     700+ words ......pipeline of drugs for the treatment of ophthalmic diseases. Dr. Shams received a medical degree...preclinical pipeline of novel agents for ophthalmic diseases, and it markets innovative diagnostic...preclinical pipeline of novel agents for ophthalmic diseases, as well as other ...

Lux Biosciences, Rutgers enter agreement

Ophthalmology Times;  October 1, 2006 ;     113 words ...FROM STAFF REPORTS Jersey City, NJ-Lux Biosciences Inc., a privately held biotechnology company specializing in ophthalmic diseases, announced it has entered into an exclusive license agreement with Rutgers, The State University of New Jersey...

Lux Biosciences Receives Orphan Drug Designation from the FDA for Two...

PR Newswire;  January 15, 2007 ;     700+ words ......company specialized in the field of ophthalmic diseases, announced today that the U.S. Food...of products for the treatment of ophthalmic diseases. The company's business strategy...targeted therapies for corresponding ophthalmic diseases, with potentially greater efficacy...

Eyetech deal gives quick access to new research

Ophthalmology Times;  June 1, 2004 ;     174 words ......Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases. The exclusive agreement gives Eyetech access to major proprietary research for generating future optimized lead compounds...

Love-Eye Association Set up in Tianjin

Xinhua English Newswire;  November 7, 1996 ;     103 words ......China. The association will focus on spreading knowledge about eyesight care in a city with a high ratio of people with ophthalmic diseases and wearers of eye glasses. It was launched after four years preparation, initiated by eye experts from Tianjin Medical...

In Vitro and In Vivo Photosensitization by Protoporphyrins Possessing...

Photochemistry and Photobiology;  September 1, 2006 ;     700+ words ......clinical trials for treatment of various oncologic and ophthalmic diseases. The main cause for cell inactivation and retardation...treatment for a variety of oncological, cardiovascular, and ophthalmic diseases (1). The treatment is based on systemic or topical administration...

Pfizer buys Angiosyn, angiostatic drug maker

Ophthalmology Times;  March 1, 2005 ;     234 words ......CA-Pfizer Inc. has acquired Angiosyn Inc., a privately held biopharmaceutical company developing an angiostatic agent for ophthalmic diseases, including age-related macular degeneration (AMD). The $527 million deal means Angiosyn would join Pfizer as a wholly...

OPKO Health to Present at UBS 2007 Global Life Sciences Conference.

PR Newswire;  September 18, 2007 ;     648 words ......developing a preclinical pipeline of novel agents for ophthalmic diseases, and it also intends to market diagnostic systems that...to develop a preclinical pipeline of novel agents for ophthalmic diseases, our ability to market diagnostic systems that complement...